Intraocular Pressure — Intraocular Pressure Variation by Pneumatic Tonometer Before and After Phacoemulsification
Citation(s)
Bigger JF, Becker B Cataracts and primary open-angle glaucoma: the effect of uncomplicated cataract extraction on glaucoma control. Trans Am Acad Ophthalmol Otolaryngol. 1971 Mar-Apr;75(2):260-72.
Poley BJ, Lindstrom RL, Samuelson TW, Schulze R Jr Intraocular pressure reduction after phacoemulsification with intraocular lens implantation in glaucomatous and nonglaucomatous eyes: evaluation of a causal relationship between the natural lens and open-angle glaucoma. J Cataract Refract Surg. 2009 Nov;35(11):1946-55. doi: 10.1016/j.jcrs.2009.05.061.
Poley BJ, Lindstrom RL, Samuelson TW Long-term effects of phacoemulsification with intraocular lens implantation in normotensive and ocular hypertensive eyes. J Cataract Refract Surg. 2008 May;34(5):735-42. doi: 10.1016/j.jcrs.2007.12.045.
Shingleton BJ, Pasternack JJ, Hung JW, O'Donoghue MW Three and five year changes in intraocular pressures after clear corneal phacoemulsification in open angle glaucoma patients, glaucoma suspects, and normal patients. J Glaucoma. 2006 Dec;15(6):494-8.
Slabaugh MA, Bojikian KD, Moore DB, Chen PP The effect of phacoemulsification on intraocular pressure in medically controlled open-angle glaucoma patients. Am J Ophthalmol. 2014 Jan;157(1):26-31. doi: 10.1016/j.ajo.2013.08.023.
Vincent SJ, Vincent RA, Shields D, Lee GA Comparison of intraocular pressure measurement between rebound, non-contact and Goldmann applanation tonometry in treated glaucoma patients. Clin Exp Ophthalmol. 2012 May-Jun;40(4):e163-70. doi: 10.1111/j.1442-9071.2011.02670.x.
Yang HS, Lee J, Choi S Ocular biometric parameters associated with intraocular pressure reduction after cataract surgery in normal eyes. Am J Ophthalmol. 2013 Jul;156(1):89-94.e1. doi: 10.1016/j.ajo.2013.02.003.
Intraocular Pressure Variation by Pneumatic Tonometer Before and After Phacoemulsification
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
